Anemia often manifests as chronic kidney disease progresses. Roxadustat is a drug engineered to inhibit HIF prolyl-hydroxylase. This allows the HIF complex to form which upregulates certain genes leading to an increased production of hemoglobin and red blood cells. Thus treating CKD related anemia.
Related Illustrations
